Pediatric surgeon from Nizhnekamsk Alexey Spiridonov introduced a new method of treatment of benign cystic neoplasms

4 December 2020, Friday

The XVII Russian Congress with international participation "Pediatrics and Pediatric Surgery in the Volga Federal District" was held on December 2 and December 3 with a broadcast center from Kazan. The event, which has become a tradition, is being held for the 17th time and for the first time in online mode. Today it has become a full-fledged Congress covering almost all specialties of children's healthcare: from sports medicine specialists to pediatric surgeons, neonatologists, neurosurgeons, endocrinologists, etc. The Congress is traditionally attended by more than 2000 participants.

The Congress was attended by specialists from Kazan, the Volga district, Moscow and St. Petersburg, scientists and physicians from neighbouring and more distant countries. Alexey Spiridonov, head of the Surgical Department #1 of the Children’s City Hospital with the Perinatal Center of Nizhnekamsk, chief part-time pediatric surgeon of the Health Authority of Nizhnekamsk Municipal District of the Republic of Tatarstan, also made a report.

The physician shared his experience of using laparoscopic technologies in the treatment of giant ovarian teratoma in a girl. A 15-year-old patient complained of increased abdominal measurements, nagging pain, and shortness of breath. The doctors found that the girl had an extensive neoplasm about 25 cm in size. Provisional diagnosis: an abdominal cyst. As a result of laparoscopic surgery, surgeons removed almost 5 liters of fluid, and then the cyst shell weighing almost 500 grams. The clinical diagnosis is a giant mature teratoma of the right ovary. On the eighth day after the surgical operation, the girl was discharged home with recovery.

This rare clinical case proved the possibility of treating benign cystic neoplasms of large and giant uterine appendages using sparing minimally invasive endosurgical techniques.

SUBSCRIBE FOR NEWS
All content on this site is licensed under
Creative Commons Attribution 4.0 International